Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Efficacy of Enhanced Contact Endoscopy in Early Detection of Laryngeal Carcinoma: A Single Center Experience.

Journal of voice : official journal of the Voice Foundation·2025
Same author

Are early post-discharge physician contacts associated with 30-day psychiatric re-hospitalisation? A nationwide claims data based retrospective cohort study in Austria free of immortal time bias.

International journal of methods in psychiatric research·2023
Same author

Effects of paediatric intensive care due to congenital heart defects on maternal mental health.

Acta paediatrica (Oslo, Norway : 1992)·2023
Same author

Selection of endogenous control and identification of significant microRNA deregulations in cervical cancer.

Frontiers in oncology·2023
Same author

Safety of nurse-directed triage intranasal fentanyl protocol for acute pain management in a European pediatric emergency department: A retrospective observational analysis.

Frontiers in pediatrics·2023
Same author

What did we learn from the previous coronavirus epidemics and what can we do better: a neuroinfectiological point of view.

European journal of neurology·2020

Related Experiment Video

Updated: Jul 6, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

[Rokitansky on atherosclerosis].

I Steiner1, J Laco

  • 1Fingerlandův ústav patologie, Lékarské fakulty UK a Fakultní nemocnice, Hradec Králové. steiner@lfhk.cuni.cz

Ceskoslovenska Patologie
|March 13, 2008
PubMed
Summary
This summary is machine-generated.

Karl Rokitansky first proposed a thrombogenic theory for atherosclerosis pathogenesis, describing plaque formation from blood-derived fibrin. His early work accurately detailed atheromatous plaques and their complications, laying groundwork for future research.

Related Experiment Videos

Last Updated: Jul 6, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

Area of Science:

  • Cardiovascular Pathology
  • Medical History

Background:

  • Karl Rokitansky's 1844 "Manual of Pathological Anatomy" introduced the first theory on atherosclerosis pathogenesis.
  • Rokitansky described plaque formation as a thickening of the vascular inner layer, composed of fibrin from blood origin.

Discussion:

  • The theory, termed "thrombogenic," accurately detailed atheromatous plaque composition and complications.
  • Rokitansky's macroscopic descriptions focused on aortic lesions, noting potential narrowing and dilatation.
  • He distinguished between atheromatous processes and ossification, though misinterpreting calcification.

Key Insights:

  • Pioneering thrombogenic theory of atherosclerosis pathogenesis.
  • Detailed macroscopic description of aortic plaques and their lipid-rich interiors.
  • Early recognition of fibrin's role in vascular plaque formation.

Outlook:

  • Subsequent editions included histological details, advancing the understanding of vascular lesions.
  • Rokitansky's foundational work influenced subsequent research into atherosclerosis.
  • His observations on plaque complications and vessel alterations remain relevant.